Garadacimab is indicated for routine prevention of recurrent attacks of hereditary angioedema in people aged twelve years of age and older.<\/p>\n
ANDEMBRY (garadacimab-gxii) injection, for subcutaneous use Initial U.S. Approval: 2025<\/strong><\/p>\n ANDEMBRY (garadacimab-gxii) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n Note:<\/strong><\/em> ANDEMBRY (garadacimab-gxii) is a monoclonal antibody prescription medication used as preventive maintenance to stop sudden, severe swelling attacks in adults and children aged 12 and older who have hereditary angioedema (HAE).\u00a0Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.<\/p>\nIs ANDEMBRY (garadacimab-gxii) available in India?<\/h4>\n
How to get ANDEMBRY Injection delivered in India?<\/h4>\n
Who can help source\u00a0ANDEMBRY Injection in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"\n\n
\n Brand Name:<\/strong><\/td>\n ANDEMBRY<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n garadacimab-gxii injection<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n Injection:
\n\u2022 200 mg\/1.2 mL solution in single-dose prefilled autoinjector (3)
\n\u2022 200 mg\/1.2 mL (167 mg\/mL) solution in single-dose prefilled syringe
\nwith needle safety device<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n CSL Behring<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n